Tanaz A. Kermani - Concepedia

Author

Tanaz A. Kermani

University of California, Los Angeles ORCID

Also Known As

T A Kermani, T. A. Kermani, T. Asvadi Kermani, T. Kermani, T.A. Kermani, TANAZ A. KERMANI, Tanaz A Kermani, Tanaz A. Kermani, Tanaz Kermani

124

Publications

5.1K

Citations

H-Index

Concepts

All Affiliations

University of California, Los Angeles Mayo Clinic in Arizona Mayo Clinic University of Pennsylvania Mayo Clinic in Florida

About

Tanaz A. Kermani is an author at University of California, Los Angeles specializing in medicine, vasculitis, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	1.3K
2	Pathology	10	10	972
3	Immunology	4	4	389
4	Medical Laboratory Science	1	1	305
5	Neurology	1	1	56

Tanaz A. Kermani

Publications

4.2K

Citations

H-Index

Page 1

	Year	Citations
Large-vessel giant cell arteritis: a cohort study Francesco Muratore, Tanaz A. Kermani, Cynthia S. Crowson, Lara D. Veeken	2014	326
Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis Tanaz A. Kermani, Kenneth J. Warrington, Cynthia S. Crowson, Annals of the Rheumatic Diseases	2012	308
Utility of Erythrocyte Sedimentation Rate and C-Reactive Protein for the Diagnosis of Giant Cell Arteritis Tanaz A. Kermani, J. Schmidt, Cynthia S. Crowson, Seminars in Arthritis and Rheumatism Autoimmune DiseaseVasculitisMedicineImmunologyHematology	2011	305
Definitions and reliability assessment of elementary ultrasound lesions in giant cell arteritis: a study from the OMERACT Large Vessel Vasculitis Ultrasound Working Group Stavros Chrysidis, Christina Duftner, Christian Dejaco, RMD Open	2018	225
Diagnostic Features, Treatment, and Outcomes of Takayasu Arteritis in a US Cohort of 126 Patients J. Schmidt, Tanaz A. Kermani, A. Kirstin Bacani, Mayo Clinic Proceedings RheumatologyUs CohortVasculitisTakayasu ArteritisDiagnostic Features	2013	222
British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis Sarah Mackie, Christian Dejaco, Simone Appenzeller, Lara D. Veeken British SocietyRheumatologyRheumatoid DisorderVasculitisRheumatic Diseases	2020	219
Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study Maël Heiblig, Marcela A. Ferrada, Matthew T. Koster, Blood	2022	194
Disease Relapses among Patients with Giant Cell Arteritis: A Prospective, Longitudinal Cohort Study Tanaz A. Kermani, Kenneth J. Warrington, David Cuthbertson, The Journal of Rheumatology	2015	178
Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis Marcela A. Ferrada, Sinisa Savic, Daniela Ospina Cardona, Blood	2022	165
Tumor necrosis factor inhibitors in patients with Takayasu arteritis: Experience from a referral center with long‐term followup J. Schmidt, Tanaz A. Kermani, A. Kirstin Bacani, Arthritis Care & Research	2012	137

Page 1